- Though Millions Are at Risk for Diabetes, Medicare Struggles to Expand Prevention Programby Harris Meyer on July 21, 2021 at 9:00 am
Medicare has proposed revamping its payment rules to get more people into a diabetes prevention plan that helps them eat better, exercise more and maintain a healthier lifestyle. Out of an estimated 16 million Medicare beneficiaries whose excess weight and other risk factors make them eligible, only 3,600 have participated since 2018.
- California Makes It Easier for Low-Income Residents to Get and Keep Free Health Coverageby Rachel Bluth, Kaiser Health News on July 20, 2021 at 9:00 am
State lawmakers aim to expand Medicaid enrollment by dedicating billions of dollars in coming years to simplifying paperwork, extending pregnancy coverage and opening the program to thousands of new enrollees, including older unauthorized immigrants and people who need nursing home care.
- Sen. Wyden: $3.5T Budget May Have to Trim but It Can Set a Path to ‘Ambitious Goals’by Michael McAuliff on July 20, 2021 at 9:00 am
Sen. Ron Wyden (D-Ore.), who is helping to negotiate the health care spending framework for the Democrats' budget plan, said lawmakers may have to settle for very basic versions of programs deployed in the package. But the key, he added, is to get the "architecture of these changes, bold changes," started and show people what is possible.
- KHN’s ‘What the Health?’: Here Comes Reconciliationon July 15, 2021 at 5:05 pm
Democrats in Congress reached a tentative agreement to press ahead on a partisan bill that would dramatically expand health benefits for people on Medicare, those who buy their own insurance and individuals who have been shut out of coverage in states that didn’t expand Medicaid. Meanwhile, controversy continues to rage over whether vaccinated Americans will need a booster to protect against covid-19 variants, and who will pay for a new drug to treat Alzheimer’s disease. Rachel Cohrs of Stat and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these issues and more. Also, Rovner interviews KHN’s Rae Ellen Bichell, who reported and wrote the latest KHN-NPR “Bill of the Month” episode about a mother and daughter who fought an enormous emergency room bill.
- Senate Democrats’ Plan Boosts Spending on Medicare, ACA Subsidies, Long-Term Careby Michael McAuliff on July 15, 2021 at 9:00 am
The plan from high-wire negotiations would affect five key areas of health, but there will be further tense negotiations among Democratic lawmakers about specifics of the $3.5 trillion in funding. And all Senate Democrats will need to be behind the plan, because Republicans oppose it.
- As Congress Wrestles With Plans to Expand Medicare, Becerra Says Any One Will Doby Julie Rovner, Kaiser Health News on July 13, 2021 at 7:30 pm
In an interview for KHN’s “What the Health?” podcast, HHS Secretary Xavier Becerra says the administration is eager for Congress to make changes to Medicare that will provide more benefits and make more older adults eligible for the program. He also said a priority will be making permanent the enhanced premium subsidies for Affordable Care Act marketplace plans.
- KHN’s ‘What the Health?’: Becerra Urges Congress to Expand Medicare, Address Rx Priceson July 13, 2021 at 7:30 pm
Health and Human Services Secretary Xavier Becerra is the special guest for this bonus episode of KHN’s “What the Health?” podcast. He and host Julie Rovner discuss a breadth of topics the secretary oversees, including covid-19, prescription drug prices, Medicare, Medicaid and the Affordable Care Act.
- Drugmakers’ Spending on Stock, Dividends and Executive Pay Exceeds Research, Democrats Sayby Michael McAuliff on July 9, 2021 at 9:00 am
The pharmaceutical industry argues that large profits are needed to fund extensive research and innovation. But Democrats on the House Oversight and Reform Committee, seeking to bolster their effort to let Medicare negotiate drug prices, say major drug companies plow more of their billions in earnings back into propping up their stock and enriching executives and shareholders.
- Paying Billions for Controversial Alzheimer’s Drug? How About Funding This Instead?by Judith Graham on July 6, 2021 at 9:00 am
Aduhelm, approved by the Food and Drug Administration last month despite questions about its efficacy, could be prescribed to at least 1 million patients a year, for a price tag of about $56 billion. Experts suggest there might be better ways to spend that money.
- Hospital Prices Must Now Be Transparent. For Many Consumers, They’re Still Anyone’s Guess.by Julie Appleby, Kaiser Health News on July 2, 2021 at 9:00 am
A Trump administration rule mandating that hospitals disclose true prices on their websites took effect this year. But compliance is spotty and even when the data is public, it’s hard to find and understand.